Some polymorphisms in genes encoding for Phase I (i.e., cytochrome p450) and Phase II components (i.e., glutathione S-transferase M1-GSTM1 and N-acetyltransferase 2-NAT2) have been associated with an increased BC risk [11]. This evidence concerns the gene NAT2 and breast cancer.